Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 6—June 2026
Dispatch
Suspected Sexual Transmission of Dermatophilosis among Men Who Have Sex with Men, Barcelona, Spain, 2025–2026
Table
Epidemiologic and clinical characteristics of dermatophilosis cases in men who have sex with men, Barcelona, Spain, December 2025–March 2026*
| Pt no. | Age, y | HIV | Travel in previous month | Chemsex | Visited sex venue in week before symptom onset | Sexual partner with symptoms | STI co-infection | Symptom duration, d | Infection site | Lesion types | Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 61 | N | London, UK | N | Y, sauna | Y | Early latent syphilis | 15 | Thorax | Vesicles, Pustules | Benzathine penicillin |
| 2 | 27 | N, on PrEP | Toulouse, France | N | Y, sauna | Y | N | 5 | Beard, penis, scrotum, thigh | Papules, vesicles, pustules | Mupirocin, doxycycline |
| 3 | 47 | Y, on ART; CD4 495 cells/mm3 | N | Y, CM | Y, sex club | N | Early latent syphilis | 10 | Buttock, scrotum, groin | Scaly papules | Cefadroxil |
| 4 | 49 | N, on PrEP | Vienna, Austria; Budapest, Hungary | N | Y, sauna | Y, pt. no. 5 | N | 6 | Beard, penis, groin | Pustules, nodules | Cefadroxil |
| 5 | 54 | N, on PrEP | Vienna, Austria; Budapest, Hungary | N | Y, sauna | Y, pt. no. 4 | N | 3 | Thigh, armpit | Vesicles, pustules | Cefadroxil |
| 6 | 32 | N | No | N | Y, sauna | N | NG, LGV, HSV-2 | 45 | Thigh | Nodules, scaly lesions | Ceftriaxone, doxycycline |
| 7 | 66 | Y, on ART; CD4 217 cells/mm3 | N | Y, CM, GHB, 4-MMC |
Y, sauna | N | No | 15 | Beard | Scaly papules, scabs | Cefadroxil |
| 8 | 29 | Y, on ART; CD4 860 cells/mm3 | N | N | Y, sauna | N | NG, CT | 4 | Scrotum | Pustules, scabs | Cefadroxil |
| 9 | 37 | Y, on ART; CD4 475 cells/mm3 | N | Y, CM, GHB | Y, sauna | N | N | 5 | Perianal, groin, thigh | Scaly papules, pustules, scabs | Cloxacillin |
*4-MMC, mephedrone; ART, antiretroviral therapy; chemsex, drug use in a sexual context; CM, methamphetamine; CT, Chlamydia trachomatis; GHB, gamma-hydroxybutyric acid; HSV-2, herpes simplex virus type 2; LGV, lymphogranuloma venereum; NG, Neisseria gonorrhoeae; PrEP: preexposure prophylaxis; STI, sexually transmitted infection; pt., patient.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.